11-63631078-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_015459.5(ATL3):​c.1501G>A​(p.Gly501Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000456 in 1,613,802 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0025 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 1 hom. )

Consequence

ATL3
NM_015459.5 missense

Scores

6
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.769

Publications

4 publications found
Variant links:
Genes affected
ATL3 (HGNC:24526): (atlastin GTPase 3) This gene encodes a member of a family of dynamin-like, integral membrane GTPases. The encoded protein is required for the proper formation of the network of interconnected tubules of the endoplasmic reticulum. Mutations in this gene may be associated with hereditary sensory neuropathy type IF. Alternatively spliced transcript variants that encode distinct isoforms have been described. [provided by RefSeq, Feb 2014]
ATL3 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory, type 1F
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary sensory and autonomic neuropathy type 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010328501).
BP6
Variant 11-63631078-C-T is Benign according to our data. Variant chr11-63631078-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474835.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 381 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATL3NM_015459.5 linkc.1501G>A p.Gly501Arg missense_variant Exon 12 of 13 ENST00000398868.8 NP_056274.3 Q6DD88

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATL3ENST00000398868.8 linkc.1501G>A p.Gly501Arg missense_variant Exon 12 of 13 1 NM_015459.5 ENSP00000381844.3 Q6DD88
ATL3ENST00000538786.1 linkc.1447G>A p.Gly483Arg missense_variant Exon 12 of 13 2 ENSP00000437593.1 F5H6I7
ENSG00000256789ENST00000540307.2 linkn.121-6413C>T intron_variant Intron 1 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.00250
AC:
380
AN:
152104
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00864
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000852
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000671
AC:
167
AN:
248926
AF XY:
0.000467
show subpopulations
Gnomad AFR exome
AF:
0.00872
Gnomad AMR exome
AF:
0.000522
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000355
Gnomad OTH exome
AF:
0.000497
GnomAD4 exome
AF:
0.000243
AC:
355
AN:
1461580
Hom.:
1
Cov.:
32
AF XY:
0.000204
AC XY:
148
AN XY:
727092
show subpopulations
African (AFR)
AF:
0.00726
AC:
243
AN:
33476
American (AMR)
AF:
0.000470
AC:
21
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.000186
AC:
16
AN:
86212
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5748
European-Non Finnish (NFE)
AF:
0.0000315
AC:
35
AN:
1111820
Other (OTH)
AF:
0.000563
AC:
34
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00250
AC:
381
AN:
152222
Hom.:
2
Cov.:
32
AF XY:
0.00231
AC XY:
172
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.00864
AC:
359
AN:
41542
American (AMR)
AF:
0.000850
AC:
13
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68010
Other (OTH)
AF:
0.00190
AC:
4
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00108
Hom.:
12
Bravo
AF:
0.00258
ESP6500AA
AF:
0.00740
AC:
30
ESP6500EA
AF:
0.000119
AC:
1
ExAC
AF:
0.000843
AC:
102
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neuropathy, hereditary sensory, type 1F Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Nov 08, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ATL3-related disorder Benign:1
Mar 20, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.032
T;.
Eigen
Benign
-0.077
Eigen_PC
Benign
-0.10
FATHMM_MKL
Benign
0.31
N
LIST_S2
Uncertain
0.91
D;D
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.010
T;T
MetaSVM
Uncertain
0.039
D
MutationAssessor
Benign
1.9
L;.
PhyloP100
0.77
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.7
N;N
REVEL
Uncertain
0.43
Sift
Benign
0.42
T;T
Sift4G
Benign
0.53
T;T
Polyphen
0.86
P;.
Vest4
0.49
MutPred
0.38
Gain of methylation at G501 (P = 0.0175);.;
MVP
0.98
MPC
1.0
ClinPred
0.012
T
GERP RS
4.4
Varity_R
0.099
gMVP
0.75
Mutation Taster
=68/32
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112847445; hg19: chr11-63398550; API